checkAd

    EQS-News  101  0 Kommentare Asklepios Group: Asklepios shows resilience in 2023 financial year

    EQS-News: Asklepios Kliniken / Key word(s): Annual Report
    Asklepios Group: Asklepios shows resilience in 2023 financial year

    25.04.2024 / 10:00 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    Asklepios Group: Asklepios shows resilience in 2023 financial year

    • Revenue at EUR 5,452.3 million
    • Number of patients treated rises 2.4% to 3.5 million
    • Number of FTEs grows thanks to effective strategies to counter the shortage of qualified staff

    Hamburg, 25 April 2024. Despite the challenges arising from persistent inflation and structural uncertainties in the healthcare sector, Asklepios Kliniken GmbH & Co. KGaA closed the 2023 financial year with sound results and demonstrated its economic resilience. The upcoming hospital reform will bring major challenges for the healthcare sector. As a strong hospital group with a stable shareholder structure, Asklepios considers itself well positioned in structural terms for the tasks that lie ahead.

    The 2023 financial year was influenced by a challenging regulatory environment, general cost inflation and price increases triggered by the ongoing war in Ukraine. Higher staff costs also had an impact on earnings. In this context, the Management Board is happy to be able to report a stable year-on-year development and to have kept consolidated net income at the previous year’s level.

    The Asklepios Group treated approximately 3.5 million patients at its 164 healthcare facilities in the 2023 financial year. Despite structural uncertainties in the healthcare sector, Asklepios thus achieved a slight increase in comparison to the previous year (2022: 3.4 million patients). The number of full-time equivalents changed from 49,103 in the previous year to 49,425 on average in 2023. This reflects how Asklepios’ commitment to recruiting specialists on the international labour market as well has paid off. Investments from its own funds amounted to EUR 229.6 million (2022: EUR 218.3 million).

    Seite 1 von 4



    EQS Group AG
    0 Follower
    Autor folgen
    Verfasst von EQS Group AG
    EQS-News Asklepios Group: Asklepios shows resilience in 2023 financial year EQS-News: Asklepios Kliniken / Key word(s): Annual Report Asklepios Group: Asklepios shows resilience in 2023 financial year 25.04.2024 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Asklepios Group: …

    Schreibe Deinen Kommentar

    Disclaimer